Susan Moloney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Susan Moloney has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
Andreas Schibler
Paediatric Critical Care Research Group, Child Health Research Centre, The University of Queensland, Brisbane, Queensland, Australia
2 shared publications- Carl Heneghan
University of Oxford
2 shared publications - Donna Franklin
Children’s Emergency and Critical Care Research Collaborative, Gold Coast University Hospital, Southport, Queensland, Australia
2 shared publications Ed Oakley
Paediatric Research in Emergency Departments International Collaborative (PREDICT), Parkville, Victoria, Australia
2 shared publications- Elizabeth Taruna Thomas
Centre for Evidence‐Based Medicine University of Oxford Oxford UK
2 shared publications Jocelyn Neutze
Paediatric Research in Emergency Departments International Collaborative (PREDICT), Parkville, Victoria, Australia
2 shared publications
Latest Publications
- Open Access
- 20 May 2026
- Published by Springer Nature in Dysphagia
- p. 1-15
Oral Feeding and Aspiration Risk in Preterm Infants Receiving Nasal High-Flow Respiratory Support: A Cross-Sectional Study
To objectively assess aspiration risk with oral feeding during nasal high-flow (NHF) and to correlate NHF rate and presence and depth (degree) of Oropharyngeal Aspiration (OPA). Cross-sectional study. Single-center, Level III, neonatal unit. Infants born preterm (< 37-weeks gestational age [GA]), aged ≥ 35-weeks to 4-weeks corrected gestational age (CGA) at an oral feeding trial, whilst receiving NHF (> 1 L/min), demonstrating oral feeding readiness cues, managing oral secretions, and clinically stable. Participants underwent a clinical feeding evaluation (CFE) and videofluoroscopic swallow study (VFSS). Aspiration status was determined using the Penetration-Aspiration Scale (PAS) on VFSS. Flow rate (L/min), weight-adjusted flow rate (L/kg/min), and fraction of inspired oxygen (FiO 2 ) were recorded at CFE and VFSS, with PAS data used for analysis. Twenty preterm infants, (13 males) were recruited. They were born at 24 weeks + 0-days to 36-weeks + 6-days GA, and aged 34-weeks + 6-days to 42-weeks + 5-days CGA at their CFE. One infant had suspected aspiration on CFE, and two had silent aspiration confirmed on VFSS. PAS ranged from 1 to 8 (median 2.00, interquartile range 1.00–2.00). Unadjusted and weight-adjusted flow rates at VFSS were 4–8 (mean±standard deviation 5.60 ± 1.27) L/min and 1.2–3.88 (2.24 ± 0.61) L/kg/min, respectively. Level of laryngeal penetration-aspiration was not correlated with flow rate (L/min; p = 0.11) but significantly inversely correlated with weight-adjusted flow rate (L/kg/min; p = 0.01). These early findings suggest that it may be safe to orally feed some clinically stable preterm infants receiving NHF under controlled conditions. Aspiration risk should be based upon patient-specific factors and not just from receiving NHF. However, additional research is needed.
- 20 May 2026
- Published by Springer Nature in Dysphagia
- p. 1-15
Open AccessOral Feeding and Aspiration Risk in Preterm Infants Receiving Nasal High-Flow Respiratory Support: A Cross-Sectional Study
To objectively assess aspiration risk with oral feeding during nasal high-flow (NHF) and to correlate NHF rate and presence and depth (degree) of Oropharyngeal Aspiration (OPA). Cross-sectional study. Single-center, Level III, neonatal unit. Infants born preterm (< 37-weeks gestational age [GA]), aged ≥ 35-weeks to 4-weeks corrected gestational age (CGA) at an oral feeding trial, whilst receiving NHF (> 1 L/min), demonstrating oral feeding readiness cues, managing oral secretions, and clinically stable. Participants underwent a clinical feeding evaluation (CFE) and videofluoroscopic swallow study (VFSS). Aspiration status was determined using the Penetration-Aspiration Scale (PAS) on VFSS. Flow rate (L/min), weight-adjusted flow rate (L/kg/min), and fraction of inspired oxygen (FiO 2 ) were recorded at CFE and VFSS, with PAS data used for analysis. Twenty preterm infants, (13 males) were recruited. They were born at 24 weeks + 0-days to 36-weeks + 6-days GA, and aged 34-weeks + 6-days to 42-weeks + 5-days CGA at their CFE. One infant had suspected aspiration on CFE, and two had silent aspiration confirmed on VFSS. PAS ranged from 1 to 8 (median 2.00, interquartile range 1.00–2.00). Unadjusted and weight-adjusted flow rates at VFSS were 4–8 (mean±standard deviation 5.60 ± 1.27) L/min and 1.2–3.88 (2.24 ± 0.61) L/kg/min, respectively. Level of laryngeal penetration-aspiration was not correlated with flow rate (L/min; p = 0.11) but significantly inversely correlated with weight-adjusted flow rate (L/kg/min; p = 0.01). These early findings suggest that it may be safe to orally feed some clinically stable preterm infants receiving NHF under controlled conditions. Aspiration risk should be based upon patient-specific factors and not just from receiving NHF. However, additional research is needed.
- 12 January 2026
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 62 (3) , 481-483
Persistent Nasal Congestion in the Newborn—Think Congenital Syphilis: A Case Report
Learning Points: Congenital syphilis can be asymptomatic, or present with subtle signs and symptoms such as persistent nasal snuffliness. As syphilis infections in women of childbearing age are increasing in Australia and many high‐income countries, paediatricians need to be aware of the symptoms and signs of congenital syphilis to enable prompt diagnosis and treatment. Infants with congenital syphilis should be nursed in contact precautions until 24 h of antibiotic therapy has been administered to prevent nosocomial transmission.
- 12 January 2026
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 62 (3) , 481-483
Persistent Nasal Congestion in the Newborn—Think Congenital Syphilis: A Case Report
Learning Points: Congenital syphilis can be asymptomatic, or present with subtle signs and symptoms such as persistent nasal snuffliness. As syphilis infections in women of childbearing age are increasing in Australia and many high‐income countries, paediatricians need to be aware of the symptoms and signs of congenital syphilis to enable prompt diagnosis and treatment. Infants with congenital syphilis should be nursed in contact precautions until 24 h of antibiotic therapy has been administered to prevent nosocomial transmission.
- Open Access
Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial)
Introduction Central venous access devices (CVADs) are commonly used for the treatment of paediatric cancer patients. Catheter locking is a routine intervention that prevents CVAD-associated adverse events, such as infection, occlusion and thrombosis. While laboratory and clinical data are promising, tetra-EDTA (T-EDTA) has yet to be rigorously evaluated or introduced in cancer care as a catheter lock. Methods and analysis This is a protocol for a two-arm, superiority type 1 hybrid effectiveness-implementation randomised controlled trial conducted at seven hospitals across Australia and New Zealand. Randomisation will be in a 3:2 ratio between the saline (heparinised saline and normal saline) and T-EDTA groups, with randomly varied blocks of size 10 or 20 and stratification by (1) healthcare facility; (2) CVAD type and (3) duration of dwell since insertion. Within the saline group, there will be a random allocation between normal and heparin saline. Participants can be re-recruited and randomised on insertion of a new CVAD. Primary outcome for effectiveness will be a composite of CVAD-associated bloodstream infections (CABSI), CVAD-associated thrombosis or CVAD occlusion during CVAD dwell or at removal. Secondary outcomes will include CABSI, CVAD-associated-thrombosis, CVAD failure, incidental asymptomatic CVAD-associated-thrombosis, other adverse events, health-related quality of life, healthcare costs and mortality. To achieve 90% power (alpha=0.05) for the primary outcome, data from 720 recruitments are required. A mixed-methods approach will be employed to explore implementation contexts from the perspective of clinicians and healthcare purchasers. Ethics and dissemination Ethics approval has been provided by Children’s Health Queensland Hospital and Health Service Human Research Ethics Committee (HREC) (HREC/22/QCHQ/81744) and the University of Queensland HREC (2022/HE000196) with subsequent governance approval at all sites. Informed consent is required from the substitute decision-maker or legal guardian prior to participation. In addition, consent may also be obtained from mature minors, depending on the legislative requirements of the study site. The primary trial and substudies will be written by the investigators and published in peer-reviewed journals. The findings will also be disseminated through local health and clinical trial networks by investigators and presented at conferences. Trial registration number ACTRN12622000499785.
Open AccessPreventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial)
Introduction Central venous access devices (CVADs) are commonly used for the treatment of paediatric cancer patients. Catheter locking is a routine intervention that prevents CVAD-associated adverse events, such as infection, occlusion and thrombosis. While laboratory and clinical data are promising, tetra-EDTA (T-EDTA) has yet to be rigorously evaluated or introduced in cancer care as a catheter lock. Methods and analysis This is a protocol for a two-arm, superiority type 1 hybrid effectiveness-implementation randomised controlled trial conducted at seven hospitals across Australia and New Zealand. Randomisation will be in a 3:2 ratio between the saline (heparinised saline and normal saline) and T-EDTA groups, with randomly varied blocks of size 10 or 20 and stratification by (1) healthcare facility; (2) CVAD type and (3) duration of dwell since insertion. Within the saline group, there will be a random allocation between normal and heparin saline. Participants can be re-recruited and randomised on insertion of a new CVAD. Primary outcome for effectiveness will be a composite of CVAD-associated bloodstream infections (CABSI), CVAD-associated thrombosis or CVAD occlusion during CVAD dwell or at removal. Secondary outcomes will include CABSI, CVAD-associated-thrombosis, CVAD failure, incidental asymptomatic CVAD-associated-thrombosis, other adverse events, health-related quality of life, healthcare costs and mortality. To achieve 90% power (alpha=0.05) for the primary outcome, data from 720 recruitments are required. A mixed-methods approach will be employed to explore implementation contexts from the perspective of clinicians and healthcare purchasers. Ethics and dissemination Ethics approval has been provided by Children’s Health Queensland Hospital and Health Service Human Research Ethics Committee (HREC) (HREC/22/QCHQ/81744) and the University of Queensland HREC (2022/HE000196) with subsequent governance approval at all sites. Informed consent is required from the substitute decision-maker or legal guardian prior to participation. In addition, consent may also be obtained from mature minors, depending on the legislative requirements of the study site. The primary trial and substudies will be written by the investigators and published in peer-reviewed journals. The findings will also be disseminated through local health and clinical trial networks by investigators and presented at conferences. Trial registration number ACTRN12622000499785.
- Open Access
Preparing for Death While Investing in Life: A Narrative Inquiry and Case Report of Home-Based Paediatric Palliative, End-of-Life, and After-Death Care
Paediatric palliative care is pivotal for addressing the complex needs of children with incurable diseases and their families. While home-based care offers a familiar and supportive environment, delivering comprehensive services in this context is challenging. The existing literature on home-based palliative care lacks detailed guidance for its organization and implementation. This qualitative narrative inquiry explores the organization and provision of home-based paediatric palliative care. Data were collected from healthcare practitioners using conversations, storytelling, and reflective journaling. Schwind’s Narrative Reflective Process was applied to synthesize the data, resulting in an in-depth case description. The narrative approach illuminates the complexities of home-based paediatric palliative, end-of-life, and after-death care. Key findings encompass the importance of early-care coordination, interprofessional collaboration, effective symptom management, emotional and psychosocial support, and comprehensive end-of-life planning. Through the case study of the child patient, the challenges and strategies for providing holistic, family-centred care within the home environment are described. Practical insights gained from this report can inform the development and improvement of home-based palliative care programs, benefiting researchers, practitioners, and policymakers seeking to optimize care for children and families in similar contexts.
Open AccessPreparing for Death While Investing in Life: A Narrative Inquiry and Case Report of Home-Based Paediatric Palliative, End-of-Life, and After-Death Care
Paediatric palliative care is pivotal for addressing the complex needs of children with incurable diseases and their families. While home-based care offers a familiar and supportive environment, delivering comprehensive services in this context is challenging. The existing literature on home-based palliative care lacks detailed guidance for its organization and implementation. This qualitative narrative inquiry explores the organization and provision of home-based paediatric palliative care. Data were collected from healthcare practitioners using conversations, storytelling, and reflective journaling. Schwind’s Narrative Reflective Process was applied to synthesize the data, resulting in an in-depth case description. The narrative approach illuminates the complexities of home-based paediatric palliative, end-of-life, and after-death care. Key findings encompass the importance of early-care coordination, interprofessional collaboration, effective symptom management, emotional and psychosocial support, and comprehensive end-of-life planning. Through the case study of the child patient, the challenges and strategies for providing holistic, family-centred care within the home environment are described. Practical insights gained from this report can inform the development and improvement of home-based palliative care programs, benefiting researchers, practitioners, and policymakers seeking to optimize care for children and families in similar contexts.
- Open Access
- 19 June 2023
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 59 (9) , 1053-1060
The quality of diagnostic guidelines for children in primary care: A meta‐epidemiological study
Aim: To determine the quality of paediatric guidelines relevant to diagnosis of three of the most common conditions in primary care: fever, gastroenteritis and constipation.Methods: We undertook a meta‐epidemiological study of paediatric guidelines for fever, gastroenteritis and gastroenteritis. We systematically searched MEDLINE, Embase, Trip Database, Guidelines International Network, the National Guideline Clearinghouse and WHO from February 2011 to September 2022 for guidelines from high‐income settings containing diagnostic recommendations. We assessed the quality of guideline reporting for included guidelines using the AGREE II tool.Results: We included 16 guidelines: fever (n = 7); constipation (n = 4) and gastroenteritis (n = 5). The overall quality across the three conditions was graded moderate (median AGREE II score 4.5/7, range 2.5–6.5) with constipation guidelines rated the highest (median 6/7), and fever rated the lowest (median 3.8/7). Major methodological weaknesses included consideration of guideline applicability. Half of the guidelines did not report involving parent representatives, and 56% did not adequately declare or address their competing interests.Conclusions: Substantial variations exist in the quality of paediatric guidelines related to the diagnosis of primary care presentations. Better quality guidance is needed for general practitioners to improve diagnosis for children in primary care.
- 19 June 2023
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 59 (9) , 1053-1060
Open AccessThe quality of diagnostic guidelines for children in primary care: A meta‐epidemiological study
Aim: To determine the quality of paediatric guidelines relevant to diagnosis of three of the most common conditions in primary care: fever, gastroenteritis and constipation.Methods: We undertook a meta‐epidemiological study of paediatric guidelines for fever, gastroenteritis and gastroenteritis. We systematically searched MEDLINE, Embase, Trip Database, Guidelines International Network, the National Guideline Clearinghouse and WHO from February 2011 to September 2022 for guidelines from high‐income settings containing diagnostic recommendations. We assessed the quality of guideline reporting for included guidelines using the AGREE II tool.Results: We included 16 guidelines: fever (n = 7); constipation (n = 4) and gastroenteritis (n = 5). The overall quality across the three conditions was graded moderate (median AGREE II score 4.5/7, range 2.5–6.5) with constipation guidelines rated the highest (median 6/7), and fever rated the lowest (median 3.8/7). Major methodological weaknesses included consideration of guideline applicability. Half of the guidelines did not report involving parent representatives, and 56% did not adequately declare or address their competing interests.Conclusions: Substantial variations exist in the quality of paediatric guidelines related to the diagnosis of primary care presentations. Better quality guidance is needed for general practitioners to improve diagnosis for children in primary care.
- Open Access
- 17 May 2023
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 41 (4) , 460-469
The quality of paediatric asthma guidelines: evidence underpinning diagnostic test recommendations from a meta-epidemiological study
Background: Asthma is one of the most frequent reasons children visit a general practitioner (GP). The diagnosis of childhood asthma is challenging, and a variety of diagnostic tests for asthma exist. GPs may refer to clinical practice guidelines when deciding which tests, if any, are appropriate, but the quality of these guidelines is unknown. Objectives: To determine (i) the methodological quality and reporting of paediatric guidelines for the diagnosis of childhood asthma in primary care, and (ii) the strength of evidence supporting diagnostic test recommendations. Design: Meta-epidemiological study of English-language guidelines from the United Kingdom and other high-income countries with comparable primary care systems including diagnostic testing recommendations for childhood asthma in primary care. The AGREE-II tool was used to assess the quality and reporting of the guidelines. The quality of the evidence was assessed using GRADE. Results: Eleven guidelines met the eligibility criteria. The methodology and reporting quality varied across the AGREE II domains (median score 4.5 out of 7, range 2–6). The quality of evidence supporting diagnostic recommendations was generally of very low quality. All guidelines recommended the use of spirometry and reversibility testing for children aged ≥5 years, however, the recommended spirometry thresholds for diagnosis differed across guidelines. There were disagreements in testing recommendations for 3 of the 7 included tests. Conclusions: The variable quality of guidelines, lack of good quality evidence, and inconsistent recommendations for diagnostic tests may contribute to poor clinician adherence to guidelines and variation in testing for diagnosing childhood asthma.
- 17 May 2023
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 41 (4) , 460-469
Open AccessThe quality of paediatric asthma guidelines: evidence underpinning diagnostic test recommendations from a meta-epidemiological study
Background: Asthma is one of the most frequent reasons children visit a general practitioner (GP). The diagnosis of childhood asthma is challenging, and a variety of diagnostic tests for asthma exist. GPs may refer to clinical practice guidelines when deciding which tests, if any, are appropriate, but the quality of these guidelines is unknown. Objectives: To determine (i) the methodological quality and reporting of paediatric guidelines for the diagnosis of childhood asthma in primary care, and (ii) the strength of evidence supporting diagnostic test recommendations. Design: Meta-epidemiological study of English-language guidelines from the United Kingdom and other high-income countries with comparable primary care systems including diagnostic testing recommendations for childhood asthma in primary care. The AGREE-II tool was used to assess the quality and reporting of the guidelines. The quality of the evidence was assessed using GRADE. Results: Eleven guidelines met the eligibility criteria. The methodology and reporting quality varied across the AGREE II domains (median score 4.5 out of 7, range 2–6). The quality of evidence supporting diagnostic recommendations was generally of very low quality. All guidelines recommended the use of spirometry and reversibility testing for children aged ≥5 years, however, the recommended spirometry thresholds for diagnosis differed across guidelines. There were disagreements in testing recommendations for 3 of the 7 included tests. Conclusions: The variable quality of guidelines, lack of good quality evidence, and inconsistent recommendations for diagnostic tests may contribute to poor clinician adherence to guidelines and variation in testing for diagnosing childhood asthma.
- Open Access
- 1 September 2021
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 43, 102095
The role of mobile phones as a possible pathway for pathogen movement, a cross-sectional microbial analysis
- 1 September 2021
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 43, 102095
Open AccessThe role of mobile phones as a possible pathway for pathogen movement, a cross-sectional microbial analysis
- Top Cited Papers
- 29 June 2020
- Published by Wiley in Public Administration Review
- Vol. 80 (4) , 671-682
Australian Quarantine Policy: From Centralization to Coordination with Mid‐Pandemic COVID‐19 Shifts
Combining a historical institutionalism approach with institutional isomorphism and punctuated equilibrium, this article analyzes quarantine policy change across 120 years of Australian quarantine history. By anchoring its analysis within specific time periods (the years before the Spanish flu, seven decades of inaction, and multiple post‐1997 pandemic updates and responses), the authors highlight when and why policies did or did not change and how the constant push‐and‐pull between state and Commonwealth institutional ownership altered policy possibilities. The heart of the analysis showcases how Australia's successful COVID‐19 response is a unique output of prior quarantine policies, institutional evolution, and mid‐pandemic alterations of key national pandemic response plans.
- 29 June 2020
- Published by Wiley in Public Administration Review
- Vol. 80 (4) , 671-682
Top Cited PapersAustralian Quarantine Policy: From Centralization to Coordination with Mid‐Pandemic COVID‐19 Shifts
Combining a historical institutionalism approach with institutional isomorphism and punctuated equilibrium, this article analyzes quarantine policy change across 120 years of Australian quarantine history. By anchoring its analysis within specific time periods (the years before the Spanish flu, seven decades of inaction, and multiple post‐1997 pandemic updates and responses), the authors highlight when and why policies did or did not change and how the constant push‐and‐pull between state and Commonwealth institutional ownership altered policy possibilities. The heart of the analysis showcases how Australia's successful COVID‐19 response is a unique output of prior quarantine policies, institutional evolution, and mid‐pandemic alterations of key national pandemic response plans.
- Open Access
Multicentre, randomised trial to investigate early nasal high—flow therapy in paediatric acute hypoxaemic respiratory failure: a protocol for a randomised controlled trial—a Paediatric Acute respiratory Intervention Study (PARIS 2)
Introduction Acute hypoxaemic respiratory failure (AHRF) in children is the most frequent reason for non-elective hospital admission. During the initial phase, AHRF is a clinical syndrome defined for the purpose of this study by an oxygen requirement and caused by pneumonia, lower respiratory tract infections, asthma or bronchiolitis. Up to 20% of these children with AHRF can rapidly deteriorate requiring non-invasive or invasive ventilation. Nasal high-flow (NHF) therapy has been used by clinicians for oxygen therapy outside intensive care settings to prevent escalation of care. A recent randomised trial in infants with bronchiolitis has shown that NHF therapy reduces the need to escalate therapy. No similar data is available in the older children presenting with AHRF. In this study we aim to investigate in children aged 1 to 4 years presenting with AHRF if early NHF therapy compared with standard-oxygen therapy reduces hospital length of stay and if this is cost-effective compared with standard treatment. Methods and analysis The study design is an open-labelled randomised multicentre trial comparing early NHF and standard-oxygen therapy and will be stratified by sites and into obstructive and non-obstructive groups. Children aged 1 to 4 years (n=1512) presenting with AHRF to one of the participating emergency departments will be randomly allocated to NHF or standard-oxygen therapy once the eligibility criteria have been met (oxygen requirement with transcutaneous saturation Ethics and dissemination Ethics approval has been obtained in Australia (HREC/15/QRCH/159) and New Zealand (HDEC 17/NTA/135). The trial commenced recruitment in December 2017. The study findings will be submitted for publication in a peer-reviewed journal and presented at relevant conferences. Authorship of all publications will be decided by mutual consensus of the research team. Trial registration number ACTRN12618000210279
Open AccessMulticentre, randomised trial to investigate early nasal high—flow therapy in paediatric acute hypoxaemic respiratory failure: a protocol for a randomised controlled trial—a Paediatric Acute respiratory Intervention Study (PARIS 2)
Introduction Acute hypoxaemic respiratory failure (AHRF) in children is the most frequent reason for non-elective hospital admission. During the initial phase, AHRF is a clinical syndrome defined for the purpose of this study by an oxygen requirement and caused by pneumonia, lower respiratory tract infections, asthma or bronchiolitis. Up to 20% of these children with AHRF can rapidly deteriorate requiring non-invasive or invasive ventilation. Nasal high-flow (NHF) therapy has been used by clinicians for oxygen therapy outside intensive care settings to prevent escalation of care. A recent randomised trial in infants with bronchiolitis has shown that NHF therapy reduces the need to escalate therapy. No similar data is available in the older children presenting with AHRF. In this study we aim to investigate in children aged 1 to 4 years presenting with AHRF if early NHF therapy compared with standard-oxygen therapy reduces hospital length of stay and if this is cost-effective compared with standard treatment. Methods and analysis The study design is an open-labelled randomised multicentre trial comparing early NHF and standard-oxygen therapy and will be stratified by sites and into obstructive and non-obstructive groups. Children aged 1 to 4 years (n=1512) presenting with AHRF to one of the participating emergency departments will be randomly allocated to NHF or standard-oxygen therapy once the eligibility criteria have been met (oxygen requirement with transcutaneous saturation Ethics and dissemination Ethics approval has been obtained in Australia (HREC/15/QRCH/159) and New Zealand (HDEC 17/NTA/135). The trial commenced recruitment in December 2017. The study findings will be submitted for publication in a peer-reviewed journal and presented at relevant conferences. Authorship of all publications will be decided by mutual consensus of the research team. Trial registration number ACTRN12618000210279
- 28 October 2019
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 31 (10) , 759-767
Assessing the adherence to guidelines in the management of croup in Australian children: a population-based sample survey
Objective: To determine the extent to which care received by Australian children presenting with croup is in agreement with Clinical Practice Guidelines (CPGs). Design: Retrospective population-based sample survey. Croup clinical indicators were derived from CPGs. Data sources/study setting: Medical records from three healthcare settings were sampled for selected visits in 2012 and 2013 in three Australian states. Data collection: Data were collected by nine experienced paediatric nurses, trained to assess eligibility for indicator assessment and adherence to CPGs. Surveyors undertook criterion-based medical record reviews using an electronic data collection tool. Results: Documented guideline adherence was lower for general practitioners (65.9%; 95% CI: 60.8–70.6) than emergency departments (91.1%; 95% CI: 89.5–92.5) and inpatient admissions (91.3%; 95% CI: 88.1–93.9). Overall adherence was very low for a bundle of 10 indicators related to assessment (4.5%; 95% CI: 2.4–7.6) but higher for a bundle of four indicators relating to the avoidance of inappropriate therapy (83.1%; 95% CI: 59.5–96.0). Conclusions: Most visits for croup were characterized by appropriate treatment in all healthcare settings. However, most children had limited documented clinical assessments, and some had unnecessary tests or inappropriate therapy, which has potential quality and cost implications. Universal CPG and clinical assessment tools may increase clinical consistency.
- 28 October 2019
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 31 (10) , 759-767
Assessing the adherence to guidelines in the management of croup in Australian children: a population-based sample survey
Objective: To determine the extent to which care received by Australian children presenting with croup is in agreement with Clinical Practice Guidelines (CPGs). Design: Retrospective population-based sample survey. Croup clinical indicators were derived from CPGs. Data sources/study setting: Medical records from three healthcare settings were sampled for selected visits in 2012 and 2013 in three Australian states. Data collection: Data were collected by nine experienced paediatric nurses, trained to assess eligibility for indicator assessment and adherence to CPGs. Surveyors undertook criterion-based medical record reviews using an electronic data collection tool. Results: Documented guideline adherence was lower for general practitioners (65.9%; 95% CI: 60.8–70.6) than emergency departments (91.1%; 95% CI: 89.5–92.5) and inpatient admissions (91.3%; 95% CI: 88.1–93.9). Overall adherence was very low for a bundle of 10 indicators related to assessment (4.5%; 95% CI: 2.4–7.6) but higher for a bundle of four indicators relating to the avoidance of inappropriate therapy (83.1%; 95% CI: 59.5–96.0). Conclusions: Most visits for croup were characterized by appropriate treatment in all healthcare settings. However, most children had limited documented clinical assessments, and some had unnecessary tests or inappropriate therapy, which has potential quality and cost implications. Universal CPG and clinical assessment tools may increase clinical consistency.